UB Paderborn / Katalog / Suche / in CDI

Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector

Nature medicine, 1999-01, Vol.5 (1), p.56-63

1999

Link zum Volltext

Verfügbarkeit prüfen

Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors

Nature medicine, 1999-01, Vol.5 (1), p.64-70

1999

Link zum Volltext

Verfügbarkeit prüfen

Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia B

Thrombosis and haemostasis, 1997, Vol.77 (5), p.944

1997

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Gene Therapy of Hemophilia B: Sustained Partial Correction in Factor IX-Deficient Dogs

Science (American Association for the Advancement of Science), 1993-10, Vol.262 (5130), p.117-119

1993

Link zum Volltext

Verfügbarkeit prüfen

Role of Botrocetin in Platelet Agglutination: Formation of an Activated Complex of Botrocetin and von Willebrand Factor

Blood, 1989-08, Vol.74 (3), p.1031-1035

1989

Link zum Volltext

Verfügbarkeit prüfen

In vivo Hepatic Gene Therapy: Complete Albeit Transient Correction of Factor IX Deficiency in Hemophilia B Dogs

Proceedings of the National Academy of Sciences - PNAS, 1994-03, Vol.91 (6), p.2353-2357

1994

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of recombinant factor IX after intravenous and subcutaneous administration in dogs and cynomolgus monkeys

Thrombosis and haemostasis, 2002-05, Vol.87 (5), p.824

2002

Link zum Volltext

Verfügbarkeit prüfen

Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs

Gene therapy, 1996-03, Vol.3 (3), p.217

1996

Link zum Volltext

Verfügbarkeit prüfen

Preservation of Hemostatic and Structural Properties of Rehydrated Lyophilized Platelets: Potential for Long-Term Storage of Dried Platelets for Transfusion

Proceedings of the National Academy of Sciences - PNAS, 1995-01, Vol.92 (2), p.397-401

1995

Link zum Volltext

Verfügbarkeit prüfen

Canine Hemophilia B Resulting from a Point Mutation with Unusual Consequences

Proceedings of the National Academy of Sciences - PNAS, 1989-12, Vol.86 (24), p.10095-10099

1989

Link zum Volltext

Verfügbarkeit prüfen

Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression

Human gene therapy, 1995-08, Vol.6 (8), p.1039-1044

1995

Link zum Volltext

Verfügbarkeit prüfen

Recombinant human factor IX : Replacement therapy, Prophylaxis, and pharmacokinetics in canine hemophilia B

Blood, 1996-10, Vol.88 (7), p.2603-2610

1996

Link zum Volltext

Verfügbarkeit prüfen

Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras

Proceedings of the National Academy of Sciences - PNAS, 1995-03, Vol.92 (7), p.2455-2459

1995

Link zum Volltext

Verfügbarkeit prüfen

Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B

The Journal of clinical investigation, 1997-08, Vol.100 (4), p.886-892

1997

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs

Proceedings of the National Academy of Sciences - PNAS, 1990-07, Vol.87 (13), p.5173-5177

1990

Link zum Volltext

Verfügbarkeit prüfen

Thrombotic thrombocytopenia induced in dogs and pigs. The role of plasma and platelet vWF in animal models of thrombotic thrombocytopenic purpura

Arteriosclerosis, thrombosis, and vascular biology, 1995-06, Vol.15 (6), p.793

1995

Link zum Volltext

Verfügbarkeit prüfen

The Roles of von Willebrand Factor and Factor VIII in Arterial Thrombosis: Studies in Canine von Willebrand Disease and Hemophilia A

Blood, 1993-05, Vol.81 (10), p.2644-2651

1993

Link zum Volltext

Verfügbarkeit prüfen

Gene transfer in the hemophilias: Retrospect and prospect

Thrombosis research, 1992-08, Vol.67 (3), p.329-338

Brinkhous, Kenneth M.

1992

Link zum Volltext

Verfügbarkeit prüfen

Efficient transfection of primary cells in a canine hemophilia B model using adenovirus-polylysine-DNA complexes

Human gene therapy, 1994-03, Vol.5 (3), p.313-322

1994

Link zum Volltext

Verfügbarkeit prüfen

Use of Venom Coagglutinin and Lyophilized Platelets in Testing for Platelet-Aggregating von Willebrand Factor

Blood, 1980-03, Vol.55 (3), p.517-520

1980

Link zum Volltext

Verfügbarkeit prüfen

Advances and controversies in blood coagulation: a 50‐year retrospective

The FASEB journal, 1992-02, Vol.6 (3), p.925-926

Brinkhous, Kenneth M.

1992

Link zum Volltext

Verfügbarkeit prüfen

The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia A

Blood, 1993-05, Vol.81 (10), p.2644-2651

1993

Link zum Volltext

Verfügbarkeit prüfen

Porcine von Willebrand disease and atherosclerosis. Influence of polymorphism in apolipoprotein B100 genotype

The American journal of pathology, 1992-02, Vol.140 (2), p.403-415

1992

Link zum Volltext

Verfügbarkeit prüfen

[12] Fixation platelets and platelet agglutination/aggregation tests

Methods in Enzymology, 1989, Vol.169, p.149-163

1989

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Inhibitory and Binding Characteristics of an Antibody Causing Acquired von Willebrand Syndrome: An Assay for von Willebrand Factor Binding by Antibody

Blood, 1985-09, Vol.66 (3), p.562-569

1985

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector

Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors

Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia B

In Vivo Gene Therapy of Hemophilia B: Sustained Partial Correction in Factor IX-Deficient Dogs

Role of Botrocetin in Platelet Agglutination: Formation of an Activated Complex of Botrocetin and von Willebrand Factor

In vivo Hepatic Gene Therapy: Complete Albeit Transient Correction of Factor IX Deficiency in Hemophilia B Dogs

Pharmacokinetics of recombinant factor IX after intravenous and subcutaneous administration in dogs and cynomolgus monkeys

Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs

Preservation of Hemostatic and Structural Properties of Rehydrated Lyophilized Platelets: Potential for Long-Term Storage of Dried Platelets for Transfusion

Canine Hemophilia B Resulting from a Point Mutation with Unusual Consequences

Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression

Recombinant human factor IX : Replacement therapy, Prophylaxis, and pharmacokinetics in canine hemophilia B

Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras

Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B

Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs

Thrombotic thrombocytopenia induced in dogs and pigs. The role of plasma and platelet vWF in animal models of thrombotic thrombocytopenic purpura

The Roles of von Willebrand Factor and Factor VIII in Arterial Thrombosis: Studies in Canine von Willebrand Disease and Hemophilia A

Gene transfer in the hemophilias: Retrospect and prospect

Efficient transfection of primary cells in a canine hemophilia B model using adenovirus-polylysine-DNA complexes

Use of Venom Coagglutinin and Lyophilized Platelets in Testing for Platelet-Aggregating von Willebrand Factor

Advances and controversies in blood coagulation: a 50‐year retrospective

The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia A

Porcine von Willebrand disease and atherosclerosis. Influence of polymorphism in apolipoprotein B100 genotype

[12] Fixation platelets and platelet agglutination/aggregation tests

Comparison of Inhibitory and Binding Characteristics of an Antibody Causing Acquired von Willebrand Syndrome: An Assay for von Willebrand Factor Binding by Antibody

Suchergebnisse filtern